RecruitingNot ApplicableNCT06415812

Evolutionary Systems Therapy for Personality Pathology

Evolutionary Systems Therapy for Early Onset of Personality Pathology: A Pilot Study on the Effectiveness and Feasibility With Adolescents and Young Adults


Sponsor

Tages Onlus

Enrollment

21 participants

Start Date

Oct 2, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Evolutionary Systems Therapy is a new form of therapy that has been previously tested in a randomized controlled trial and in a few cases of patients diagnosed with Cluster A personality disorders. The objective of the present study is to investigate the feasibility and preliminary efficacy of Evolutionary Systems Therapy in all forms of personality disorders. The study includes three project actions: (i) a case series on adolescents with personality disorders; (ii) a case series on young adults with personality disorders; (iii) an ecological momentary assessment study to confirm the conceptualization model on all the patients.


Eligibility

Min Age: 16 YearsMax Age: 25 Years

Inclusion Criteria2

  • Being diagnosed with personality pathology in accordance with Structured Clinical Interview for DSM-5 - Alternative Model of Personality Disorders Module I
  • Being capable of read and sign the inform consent form

Exclusion Criteria5

  • Being diagnosed with schizophrenia spectrum disorders and other psychosis
  • Being diagnosed with bipolar disorders
  • Being diagnosed with autism spectrum disorder
  • Being diagnosed with intellectual disability
  • Being under any psychopharmacological or psychosocial treatment

Interventions

BEHAVIORALEvolutionary Systems Therapy

Evolutionary Systems Therapy is an individual form of psychotherapy (talk therapy) that has been previously tested trough a randomized controlled trial and a few cases series, confirming its feasibility and safety.


Locations(1)

Centro di Psicologia e Psicoterapia Tages Onlus - Firenze

Florence, FI, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06415812


Related Trials